A comparative pilot study of symptom improvement before and after phototherapy in Korean patients with perennial allergic rhinitis

Heung Man Lee, Man Sik Park, Il Ho Park, Seung Hoon Lee, Seong Keon Lee, Kyu Sung Kim, Hyuk Choi

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Although allergic rhinitis is not life threatening, it significantly influences the quality of a patient's life. This study is intended to evaluate the safety and efficacy of phototherapy with low-level energy of a 650 nm laser irradiation system in perennial allergic rhinitis patients. This clinical trial was an open-label, single-center study with 42 perennial allergic rhinitis subjects. Following laser irradiation in the nasal cavity with a laser irradiation system, the efficacy at weeks 1 through 4 was determined. The symptoms were scored with four parameters (nasal obstruction, rhinorrhea, sneezing and itching) before and after illumination of the laser, and the total score was recorded. A survey of Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ) was conducted by patients before and after treatment. Following treatment, significant improvement in the clinical symptoms of nasal obstruction (P < 0.001), rhinorrhea (P = 0.005), sneezing (P = 0.001) and itching (P = 0.003) was reported by 68% of perennial allergic rhinitis patients. The overall RQLQ scores significantly improved by 45% from the baseline with the treatment after 4 weeks. These results indicate that phototherapy is an effective modality for treating perennial allergic rhinitis and is another option in the steroid-free management of immune-mediated mucosal diseases.

Original languageEnglish
Pages (from-to)751-757
Number of pages7
JournalPhotochemistry and Photobiology
Volume89
Issue number3
DOIs
Publication statusPublished - 2013 May 1

Fingerprint

Rhinitis, Allergic, Perennial
Phototherapy
Laser beam effects
sneezing
itching
Lasers
Sneezing
Nasal Obstruction
Pruritus
irradiation
lasers
Quality of Life
Electron energy levels
steroids
Labels
Nasal Cavity
Lighting
Steroids
safety
Therapeutics

ASJC Scopus subject areas

  • Physical and Theoretical Chemistry
  • Biochemistry
  • Medicine(all)

Cite this

A comparative pilot study of symptom improvement before and after phototherapy in Korean patients with perennial allergic rhinitis. / Lee, Heung Man; Park, Man Sik; Park, Il Ho; Lee, Seung Hoon; Lee, Seong Keon; Kim, Kyu Sung; Choi, Hyuk.

In: Photochemistry and Photobiology, Vol. 89, No. 3, 01.05.2013, p. 751-757.

Research output: Contribution to journalArticle

@article{e02607916e2c4a8d994903585ab7d9a1,
title = "A comparative pilot study of symptom improvement before and after phototherapy in Korean patients with perennial allergic rhinitis",
abstract = "Although allergic rhinitis is not life threatening, it significantly influences the quality of a patient's life. This study is intended to evaluate the safety and efficacy of phototherapy with low-level energy of a 650 nm laser irradiation system in perennial allergic rhinitis patients. This clinical trial was an open-label, single-center study with 42 perennial allergic rhinitis subjects. Following laser irradiation in the nasal cavity with a laser irradiation system, the efficacy at weeks 1 through 4 was determined. The symptoms were scored with four parameters (nasal obstruction, rhinorrhea, sneezing and itching) before and after illumination of the laser, and the total score was recorded. A survey of Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ) was conducted by patients before and after treatment. Following treatment, significant improvement in the clinical symptoms of nasal obstruction (P < 0.001), rhinorrhea (P = 0.005), sneezing (P = 0.001) and itching (P = 0.003) was reported by 68{\%} of perennial allergic rhinitis patients. The overall RQLQ scores significantly improved by 45{\%} from the baseline with the treatment after 4 weeks. These results indicate that phototherapy is an effective modality for treating perennial allergic rhinitis and is another option in the steroid-free management of immune-mediated mucosal diseases.",
author = "Lee, {Heung Man} and Park, {Man Sik} and Park, {Il Ho} and Lee, {Seung Hoon} and Lee, {Seong Keon} and Kim, {Kyu Sung} and Hyuk Choi",
year = "2013",
month = "5",
day = "1",
doi = "10.1111/php.12032",
language = "English",
volume = "89",
pages = "751--757",
journal = "Photochemistry and Photobiology",
issn = "0031-8655",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - A comparative pilot study of symptom improvement before and after phototherapy in Korean patients with perennial allergic rhinitis

AU - Lee, Heung Man

AU - Park, Man Sik

AU - Park, Il Ho

AU - Lee, Seung Hoon

AU - Lee, Seong Keon

AU - Kim, Kyu Sung

AU - Choi, Hyuk

PY - 2013/5/1

Y1 - 2013/5/1

N2 - Although allergic rhinitis is not life threatening, it significantly influences the quality of a patient's life. This study is intended to evaluate the safety and efficacy of phototherapy with low-level energy of a 650 nm laser irradiation system in perennial allergic rhinitis patients. This clinical trial was an open-label, single-center study with 42 perennial allergic rhinitis subjects. Following laser irradiation in the nasal cavity with a laser irradiation system, the efficacy at weeks 1 through 4 was determined. The symptoms were scored with four parameters (nasal obstruction, rhinorrhea, sneezing and itching) before and after illumination of the laser, and the total score was recorded. A survey of Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ) was conducted by patients before and after treatment. Following treatment, significant improvement in the clinical symptoms of nasal obstruction (P < 0.001), rhinorrhea (P = 0.005), sneezing (P = 0.001) and itching (P = 0.003) was reported by 68% of perennial allergic rhinitis patients. The overall RQLQ scores significantly improved by 45% from the baseline with the treatment after 4 weeks. These results indicate that phototherapy is an effective modality for treating perennial allergic rhinitis and is another option in the steroid-free management of immune-mediated mucosal diseases.

AB - Although allergic rhinitis is not life threatening, it significantly influences the quality of a patient's life. This study is intended to evaluate the safety and efficacy of phototherapy with low-level energy of a 650 nm laser irradiation system in perennial allergic rhinitis patients. This clinical trial was an open-label, single-center study with 42 perennial allergic rhinitis subjects. Following laser irradiation in the nasal cavity with a laser irradiation system, the efficacy at weeks 1 through 4 was determined. The symptoms were scored with four parameters (nasal obstruction, rhinorrhea, sneezing and itching) before and after illumination of the laser, and the total score was recorded. A survey of Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ) was conducted by patients before and after treatment. Following treatment, significant improvement in the clinical symptoms of nasal obstruction (P < 0.001), rhinorrhea (P = 0.005), sneezing (P = 0.001) and itching (P = 0.003) was reported by 68% of perennial allergic rhinitis patients. The overall RQLQ scores significantly improved by 45% from the baseline with the treatment after 4 weeks. These results indicate that phototherapy is an effective modality for treating perennial allergic rhinitis and is another option in the steroid-free management of immune-mediated mucosal diseases.

UR - http://www.scopus.com/inward/record.url?scp=84876808838&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84876808838&partnerID=8YFLogxK

U2 - 10.1111/php.12032

DO - 10.1111/php.12032

M3 - Article

VL - 89

SP - 751

EP - 757

JO - Photochemistry and Photobiology

JF - Photochemistry and Photobiology

SN - 0031-8655

IS - 3

ER -